ResearcherUniversity of MilanNo recent work listed

Andrea Galbiati

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0725-0726; OpenAlex author ID A5072080476. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells. Co-author DOI 10.1016/j.ejmech.2023.115286 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Raffaella Pacchiana · 1 shared paper, 2023 · strength 0.18
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Chiara Borsari · 1 shared paper, 2023 · strength 0.18
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Paola Conti · 1 shared paper, 2023 · strength 0.18
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗
Massimo Donadelli · 1 shared paper, 2023 · strength 0.18
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.